|
|
||||||||
1From the Childrens Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada; and the 2University of Ottawa Eye Institute, Ottawa, Ontario, Canada; the 3Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; and the 4University Of Florida College of Medicine, Gainesville, Florida.
PURPOSE. To evaluate the neuroprotective effects of adenoassociated virus delivery of XIAP in N-methyl-N-nitrosourea (MNU)-induced retinal degeneration in Sprague-Dawley rats.
METHODS. Sprague-Dawley rats were injected subretinally with recombinant adenoassociated virus (rAAV) encoding either XIAP or green fluorescent protein (GFP; injection control). Six weeks after injection, the animals received an intraperitoneal injection of MNU, a DNA methylating agent, at a dose of 60 mg/kg. Electroretinograms (ERGs) were recorded at 0, 24, 48 and 72 hours and 1 week after MNU. The rats were killed after the ERG was performed and were perfused with 4% paraformaldehyde. Eyes were then enucleated and embedded for cryosectioning. Eye sections were analyzed by TUNEL and histologic techniques. Real-time PCR and Western analysis were performed to confirm the overexpression of XIAP in injected eyes.
RESULTS. Real-time PCR and Western analysis confirmed the overexpression of XIAP in virus-injected eyes in comparison to uninjected control eyes. At 24 hours after MNU injection, fewer cells had undergone apoptosis in the XIAP-treated eyes in comparison with GFP-injected or uninjected eyes. Hematoxylin and eosin staining revealed that the uninjected and GFP-injected photoreceptors were destroyed by 72 hours after injection of MNU, whereas the AAV-XIAP-injected eyes showed structural protection of the photoreceptors at all time points throughout the 1-week sampling period. ERGs showed functional protection up to 1 week after MNU injection in the AAV-XIAPinjected eye, whereas no response was observed in the control eye.
CONCLUSIONS. The results suggest that XIAP is protective against this potent chemotoxic agent and holds promise as a therapeutic agent in gene therapy approaches to treating retinitis pigmentosa.
This article has been cited by other articles:
![]() |
J. A. Emamaullee and A.M. J. Shapiro Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation. Diabetes, July 1, 2006; 55(7): 1907 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshioka, T. Abe, R. Wakusawa, T. Moriya, S. Mochizuki, Y. Saigo, T. Saito, H. Murata, Y. Tokita, T. Iseya, et al. Recombinant AAV-Transduced Iris Pigment Epithelial Cell Transplantation May Transfer Vector to Native RPE but Suppress Systemic Dissemination Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 745 - 752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |